Alzamend Neuro 10-K Annual Report 2021

Alzamend Neuro's fiscal 2021 Form 10-K annual report to the SEC filed by the NASDAQ-listed company. The report provides comprehensive financial statements, management discussion and analysis, and disclosure of business operations, risk factors, and corporate governance for the year ended April 30, 2021.